Oorsprong van het eerstegraads netwerk van Bruce G. Bernstein
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
BTG International, Inc.
BTG International, Inc. Investment ManagersFinance BTG International Inc. (BTG International) is a venture capital subsidiary of BTG Ltd founded in 1981. The firm is headquartered in West Conshohocken, Pennsylvania.
3
| Extinct | Investment Managers | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Bruce G. Bernstein via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Washington University in St. Louis | College/University | Undergraduate Degree | |
FIBROCELL SCIENCE, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aventis, Inc. | Corporate Officer/Principal | ||
Elan Drug Delivery, Inc.
Elan Drug Delivery, Inc. Pharmaceuticals: MajorHealth Technology Part of Perrigo Co. Plc, Elan Drug Delivery, Inc. is engaged in manufacturing, fabricating, or processing drugs in pharmaceutical preparations for human or veterinary use. The company is based in King Of Prussia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Embera NeuroTherapeutics, Inc.
Embera NeuroTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Embera NeuroTherapeutics, Inc. develops treatments for smoking cessation, cocaine dependence and other addictions. The company was founded by Nicholas Edward Goeders and Marie A. Lindner in 2005 and is headquartered in Sudbury, MA. | Pharmaceuticals: Major | Founder | |
GE Ventures LLC
GE Ventures LLC Investment ManagersFinance GE Ventures LLC (GE Ventures) is a venture capital subsidiary of General Electric Co. founded in 2000 by James Kim. The firm is headquartered in Menlo Park, California. | Investment Managers | Corporate Officer/Principal | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stanford University | College/University | Graduate Degree | |
BTG | Pharmaceuticals: Major | Corporate Officer/Principal | |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Private Equity Investor | |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Graduate Degree | |
Rosalind Franklin University of Medicine & Science | College/University | Graduate Degree | |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
ELAN CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of California | College/University | Graduate Degree | |
Harvard Business School | College/University | Graduate Degree | |
The University of Chicago Law School | College/University | Graduate Degree | |
Rotterdam School of Management | College/University | Graduate Degree | |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx Ltd (FutuRx ) is a venture capital firm founded in 2014. The firm is headquartered in Ness Ziona. | Investment Managers | Consultant / Advisor | |
Orthogon Therapeutics LLC
Orthogon Therapeutics LLC Pharmaceuticals: MajorHealth Technology Orthogon Therapeutics LLC is a privately held R&D firm that specializes in drug discovery and development. The company is based in Canton, MA. The company is headquartered in the biotech hub of Greater Boston and has a branch in Leuven. Orthogon uses an innovative structure-based and biophysics platform to design novel medicines. The company's portfolio of infectious disease assets includes antiviral therapeutics, with a lead program being a first-in-class, orally administrable small molecule inhibitor of BK virus replication. Orthogon has secured over $12.50m in investment to date and has additional discovery programs, including a treatment for antibiotic-resistant bacterial infections. The company was founded by Ali Munawar, a veteran biotech entrepreneur, and experienced drug discovery scientists with a mission to prolong and improve patient quality of life. | Pharmaceuticals: Major | Director/Board Member | |
Giiant Pharma, Inc.
Giiant Pharma, Inc. BiotechnologyHealth Technology Giiant Pharma, Inc. is a Canadian preclinical-stage biotech company that specializes in designing gut-restricted small molecule drug therapeutics with various biological targets in gastroenterology. The company is based in Montréal, Canada and was founded by Elizabeth Elizabeth Kwong. The company's proprietary precision delivery technology platform allows for the creation of tissue-specific drugs with improved tolerability and enhanced therapeutic effects. Giiant's first lead program, GT-2108, is a microbiota-activated PDE4 inhibitor prodrug. Maxime Ranger has been the CEO of the company since 2021. | Biotechnology | Director/Board Member | |
BioCurate Pty Ltd. | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 18 |
Zwitserland | 2 |
Verenigd Koninkrijk | 2 |
Japan | 2 |
Ierland | 2 |
Sectoraal
Health Technology | 12 |
Consumer Services | 9 |
Finance | 4 |
Process Industries | 2 |
Operationeel
Corporate Officer/Principal | 12 |
Graduate Degree | 7 |
Director/Board Member | 6 |
Independent Dir/Board Member | 3 |
Private Equity Investor | 2 |
Sterkste connecties
Insiders | |
---|---|
Marie Lindner | 18 |
Chris Haase | 8 |
Janet Rush | 2 |
- Beurs
- Insiders
- Bruce G. Bernstein
- Bedrijfsconnecties